Dr. Xiongfei Wu

Nephrologist
Renmin Hospital of Wuhan University, China


Highest Degree
M.D. in Nephrology from Renmin Hospital of Wuhan University, China

Share this Profile

Area of Interest:

Biomedical Sciences
Kidney
Kidney Cancer
Kinases and Phosphatases
Transplant

Selected Publications

  1. Zhang, L., P. Li, C.Y. Xing, J.Y. Zhao and Y.N. He et al., 2014. Efficacy and safety of Abelmoschus manihot for primary glomerular disease: a prospective, multicenter randomized controlled clinical trial. Am. J. Kidney Dis., 64: 57-65.
    CrossRef  |  PubMed  |  Direct Link  |  

  2. Chen, N., X. Wu, X. Ding, C. Mei and P. Fu et al., 2014. Sevelamer carbonate lowers serum phosphorus effectively in haemodialysis patients: A randomized, double-blind, placebo-controlled, dose-titration study. Nephrol. Dial. Transplant., 29: 152-160.
    CrossRef  |  PubMed  |  Direct Link  |  

  3. Shen, B., S. Zhou, Y. He, H. Zhao, M. Mei and X. Wu, 2013. Revealing the underlying mechanism of ischemia reperfusion injury using bioinformatics approach. Kidney Blood Press Res., 38: 99-108.
    CrossRef  |  PubMed  |  Direct Link  |  

  4. Ding, H., X. Wu and W. Gao, 2005. PD-L1 is expressed by human renal tubular epithelial cells and suppresses t cell cytokine synthesis. Clin Immunol., 115: 184-191.
    CrossRef  |  PubMed  |  Direct Link  |